Background: Chinese medicine theory shows that "lung being connected with large intestine", and the modern western
Introduction
Acute respiratory distress syndrome (ARDS) refers to the acute hypoxic respiratory failure, which is caused by alveolar damage induced by inflammatory injury of pulmonary capillary endothelial cells and alveolar epithelial cells in the process of severe infection, shock, trauma and burns, and with the pathological physiological characteristics of fewer lung volume, lower lung compliance, serious imbalance of ventilation/blood flow ratio (Bernard et al., 1994 ).
According to the ARDS diagnosis standards put forward by the medical conference in Berlin, Germany in October 2011, a draft definition proposed 3 mutually exclusive categories of ARDS, based on degree of hypoxemia: mild (200 mm Hg ＜ PaO 2 /FIO 2 ≤ 300 mm Hg), moderate (100 mm Hg ＜ PaO 2 /FIO 2 ≤ 200 mm Hg), and severe (PaO 2 /FIO 2 ≤ 100 mm Hg), and 4 ancillary variables for severe ARDS: radiographic severity, respiratory system compliance (≤40 mL/cm H 2 O), positive end-expiratory pressure (≥10 cm H 2 O), and corrected expired volume per minute (≥10 L/min) (ARDS Definition Task Force, 2012). Overall, it is a dangerous disease with a very poor prognosis and the mortality rate can reach as high as 40%-50% [Li et al., 2009 ]. According to the existing evidence, we can increase the intensity of treatment measures in accordance with the severity of ARDS [Liu et al., 2012] . Due to the heterogeneity of ARDS disease, however, treatment should be tailored according to the case of each patient. Therefore, in clinical decision making, we need to evaluate the benefit and risk of various treatment approaches based on the evidence-based medicine, in order to develop individualized treatment plans for each patient and ensure high clinical benefits for all. At present, many doctors act according to the theory of the interior-exterior relationship between the lung and the large intestine, and adopt a treatment methodology of combining Rheum palmatum L. with the routine comprehensive approach to treat ARDS, and procure a certain effect. Up to this day, a systematic evaluation about Rheum palmatum L. combined with routine comprehensive therapy for treating ARDS has not been reported. Therefore, it was deemed necessary to conduct a systematic review of the method of applying Rheum palmatum L. in combination with the routine comprehensive approach to treat ARDS, in order to provide solid scientific reference that would facilitate a reasonable individualized treatment plan for ARDS patients.
Methods and Materials
The supporting PRISMA checklist is available as supporting information; see Checklist Fig. S1 .
Search strategies and study selection
Literature search was conducted in the National Knowledge Infrastructure (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) , VIP Database for Chinese Technical Periodicals , PubMed (1950 PubMed ( -2015 , Chinese Bio-Medical Literature Database (1990 Database ( -2015 , and Cochrane Library (Issue 10 of 12, 2015) . All of these searches ended at the end of December 2015. To search the databases, we used the terms "Acute respiratory distress syndrome", "Acute lung injury", "Western medicine", "Rheum palmatum L. combined with western medicine", and "TCM combined with Western medicine". These terms were combined variously and used according to the database searched. The bibliographies of the included trials were searched for additional references. The data of the included trials were extracted independently by two authors (Y. Liu and T. Z. Yang). The extracted data analyzed in this study mainly included paper authors, publication year, study size, details of methodological information, drug name and outcome indicators (for example, total effective rate).
Disagreement between us was resolved by group discussion and reached consensus through a third party (J. X. Chen).
Inclusion Criteria
All the parallel-randomized controlled trials (RCTs) must be based on the principle of participants, interventions, 
Trial quality assessment
The quality of included trials was evaluated by two authors (Y. Liu and T. Z. Yang) and assessed by using the "risk of bias" assessment tool according to the "Cochrance Handbook of Systematic Review of Interventions" (Chapter 8.5) with randomized controlled trials including: sequence generation, allocation concealment, blinding, incomplete outcome date, and selective outcome reporting. The quality of all the included trials was divided into 3 categories as low, unclear, and high risk of bias. Trials that met all the criteria were classified to low risk of bias, trials met none of the criteria were classified to high risk of bias, and other trials with insufficient information acquired to make judgment were classified to unclear risk of bias ( Figure S2 .1 and S2.2).
Data analysis
The data was analyzed by using the statistical package (RevMan 5.0) provided by the Cochrane Collaboration.
Measurement data were summarized by using Mean Difference (MD) with 95% confidence interval (CI) for continuous outcomes. Fixed-effect or random-effect model used in the analysis depended on the absence or presence of significance heterogeneity which was evaluated by the Chi-square and I-square (I 2 ) tests. Measurement data with the same unit were summarized by using weight mean difference (WMD) with 95% CI, and the Measurement data with different unit were summarized by using standardized mean difference (SMD) with 95% CI (Altuntas et al., 2006) .
Results

Description of included studies
The flow chart depicts the whole search process and study selection (Figure 1-X) . After searching the six databases, 140 citations were screened. 54 articles were searched in the CBM database, 19 articles were retrieved from VIP, 49 articles were searched in CNKI and 4 articles were retrieved from PubMed. There was no related literature retrieved in the Cochrane Library. 83 papers were excluded due to duplicated publication. 22 of them were excluded on account of obvious ineligibility, which contained irrelevant titles and abstracts content. 27 articles were excluded by reason of non-RCTs, incomplete data, unqualified control, and so on. Tables 1 and 2. A total of 489 participants with ALI/ARDS were involved in these studies, with the average number of 61 per trial, ranging from 31 to 100. All the included RCTs in this study were conducted in China and published in Chinese, no one published in English. The quality of the included studies was low, but the baseline of the experimental group and control group was good (Tables 1 and 2 
Comparison of clinical mortality rate
Publication bias
Seven trials compared the effect of the two therapeutic modalities in ameliorating the clinical mortality rates in ARDS patients. A funnel plot analysis showed a serious asymmetry in the general effective rate among the 7 trials (Figure 11-X) . It indicated that the included literatures suffer from low quality and publication bias. Because of the limited number of papers, the result of this systematic review is deemed useful only for reference.
Discussion
There are more than 100 kinds of etiologic factors for ARDS. The various factors inducing ARDS differ in their pathological process and prognosis, and, therefore, the causes are divided into two main categories: direct lung injury and indirect lung injury. The former mainly includes severe pulmonary infection, aspiration, pulmonary contusion, drowning, pulmonary embolism and oxygen poisoning. The latter mainly involves severe sepsis and septic shock, severe non-pulmonary trauma, acute fatal pancreatitis, large area burns, and so on. The most common causes for ARDS are severe infection, shock, trauma and burn (He et al., 2011) . Although the etiology of ARDS is complex, its pathogenesis is also not yet fully elucidated. However, it has been demonstrated that the common "central link" of the pathogenesis is the inflammatory process mediated by inflammatory mediators released by a variety of effector cells (Gu et al., 2007) . In recent years, the role of inflammation mediators, especially the cytokines, has been gathering more attention for explaining the pathogenesis of ARDS.
Traditional Chinese Medicine believes that ARDS belongs to the pathology of "syndrome characterized by dyspnea", "sudden attack of wheezing and dyspnea" and "collapse syndrome caused by dyspnea". Severe pulmonary contusion leads to stagnancy of qi and blood, and impaired dispersion of the lung qi, and thus disturbing the and this shows that the safety of Rheum palmatum L. combined with routine comprehensive therapy is better than routine comprehensive therapy alone, to some extent. We also considered some limitations of this article before accepting the findings. Firstly, the obtained literatures of RCTs in treating ARDS by using Rheum palmatum L. combined with routine comprehensive therapy were originally published in Chinese, and no English translation exists.
Secondly the methodologies of these clinical trials were generally of very poor quality, according to the quality assessment tool for quantitative studies, and it also indicated that there is unclear risk of bias in most of trials. The methods of randomization and allocation concealment in those trials were described inadequately or incompletely. Most randomized studies did not follow the established rules. For example, none of the included 8 trials mentioned any single blind without providing detailed information, and we understood that it was difficult to perform double-blinding or single-binding because of the peculiarity of ARDS and certain features associated with Chinese herbs, for example, aroma and appearance, while it could be feasible that binding to outcome assessor and data analyzer. None of the trials explained the concrete method of randomization, and the rest merely provided insufficient information for judging whether or not it was conducted properly. The lack of dropout or withdrawal and insufficient side-effect reports were some of the factors that negatively impacted the reliability of this review. Thirdly, there was lack of placebo control in the included RCTs. One trail claimed that they used placebo control. However, the placebo of these trial is ulinastatin (Weng et al., 2008) , not Chinese herbs, and it is not an appropriate control for the estimation of the effect of Chinese herbs. Therefore, it should be made with caution, when interpreting the positive outcomes of treatment with Chinese medicine. To remedy this situation, we suggest using caution when referencing these studies in the future.
The quality of the clinical research methodology of using Rheum palmatum L. combined with routine comprehensive therapy in the treatment of ARDS should be improved. In addition, the following aspects should be emphasized. Firstly, the production of random allocation sequences and the hidden random schemes should be reported in detail. Secondly, double blind method and placebo control should be applied. Thirdly, the withdrawal and drop-out rate should be clearly described. Fourthly, the importance of clinical outcome in a long-term follow-up should be reported. The effect of the treatment of the ARDS with Rheum palmatum L. combined with routine comprehensive therapy should be improved by designing strict double blind, randomized, controlled trials.
We hope that future clinical research would be sufficiently designed to avoid the limitations of current research methodologies. A revised design should pay particular attention to the use of the final therapeutic effect index, which in the cases we examined was highly objective, and thus allow international recognition that would facilitate future exchanges.
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